Skip to main content
. Author manuscript; available in PMC: 2018 Aug 1.
Published in final edited form as: J Genet Couns. 2016 Dec 5;26(4):738–751. doi: 10.1007/s10897-016-0044-9

Table 3.

Number of complex disease and pharmacogenomics reports viewed

OSU-CPMC Mean # Complex Disease
Reports
Mean #
Pharmacogenomic
Reports
By the time of in-person GC 6.9 (range: 1–10) 1.7 (range: 0–3)
By the time of phone
interview
8.6 (range: 4–18) 2.7 (range: 0–5)
CPMC
By the time of telephone GC 10.9 (range: 2–19) 3.1 (range: 0–5)
By the time of phone
interview
14.6 (range: 5–19) 4.3 (range: 0–7)

OSU-CPMC: Chronic Disease cohort receiving in-person GC

CPMC: CPMC cohort receiving telephone GC